Department of Hepatobiliary Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;
Department of Imaging,Jinan City People's Hospital,Shandong First Medical University,Jinan 271199,Shandong Province,China;
Programmed cell death 1/programmed cell death ligand 1 inhibitors; Targeted therapy; Hepatocellular carcinoma; Programmed cell death 1; Programmed cell death ligand 1;